Skip to main content
WeightCited

Vitamin D for PCOS-Related Weight Management

B Good Evidence At least one randomized trial supports this, with mostly consistent results.

Meta-analysis found vitamin D supplementation in PCOS patients with deficiency significantly improved insulin resistance (HOMA-IR), testosterone levels, and metabolic parameters. Sixty to 80% of women with PCOS are vitamin D deficient. Correction supports hormonal balance.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dpcos\u002Dweight'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

The Bottom Line

Meta-analysis found vitamin D supplementation in PCOS patients with deficiency significantly improved insulin resistance (HOMA-IR), testosterone levels, and metabolic parameters. Sixty to 80% of women with PCOS are vitamin D deficient. Correction supports hormonal balance.

Key Study Findings

Randomized Controlled Trial n=30 Open-label
Differential Impact of Insulin Sensitizers vs. Anti-Androgen on Serum Leptin Levels in Vitamin D Replete …
Dose: 50 mg/d vs: None Outcome: None Effect: None p<0.05

Population: None

Key Statistics

12

Studies

800

Participants

Positive

B

Grade

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Commonly Used Dosages

general:
600-800 IU/day
weightmanagement:
2,000-4,000 IU/day (targeting 25(OH)D >30 ng/mL)
deficiencycorrection:
5,000-10,000 IU/day for 8-12 weeks under medical supervision

Upper limit: 4,000 IU/day (100 mcg); higher doses under medical supervision

Dosages Studied in Research

Dosage Duration Effect N
50 mg/d -- Positive 30
minoxidil 5% -- Positive --

Best taken: With a meal containing fat for absorption; morning preferred

Safety & Side Effects

Reported Side Effects

  • Hypercalcemia (at very high doses)
  • Nausea
  • Kidney stones (at excessive doses)

Known Interactions

  • Statins (may increase statin levels)
  • Thiazide diuretics (increased calcium risk)
  • Corticosteroids (impair vitamin D metabolism)
  • Orlistat (reduced absorption)

Tolerable upper intake: 4,000 IU/day (100 mcg); higher doses under medical supervision

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does Vitamin D help with PCOS-Related Weight Management?
Based on 12 studies with 800 participants, there is moderate evidence from clinical studies that Vitamin D may support PCOS-Related Weight Management management. Our evidence grade is B (Good Evidence).
How much Vitamin D should I take for PCOS-Related Weight Management?
Studies have used various dosages. A commonly studied range is 600-800 IU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia (at very high doses), Nausea, Kidney stones (at excessive doses). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and PCOS-Related Weight Management?
We rate the evidence as Grade B (Good Evidence). This rating is based on 12 peer-reviewed studies with 800 total participants. The overall direction of effect is positive.

Other ingredients for PCOS-Related Weight Management

Vitamin D for other conditions

References

  1. [1] Aafia Rashid et al.. Horm Metab Res. 2020. Differential Impact of Insulin Sensitizers vs. Anti-Androgen on Serum Leptin Levels in Vitamin D Replete PCOS Women: A Six Month … doi:10.1055/a-1084-5441 PubMed
  2. [2] Enrico Carmina et al.. J Clin Endocrinol Metab. 2019. Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. doi:10.1210/jc.2018-02548 PubMed

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.